OBJECTIVE: Immune responses are important in dictating non-alcoholic steatohepatitis (NASH) outcome. We previously reported that upregulation of hedgehog (Hh) and osteopontin (OPN) occurs in NASH, that Hh-regulated accumulation of natural killer T (NKT) cells promotes hepatic stellate cell (HSC) activation, and that cirrhotic livers harbour large numbers of NKT cells. DESIGN: The hypothesis that activated NKT cells drive fibrogenesis during NASH was evaluated by assessing if NKT depletion protects against NASH fibrosis; identifying the NKT-associated fibrogenic factors; and correlating plasma levels of the NKT cell-associated factor OPN with fibrosis severity in mice and humans. RESULTS: When fed methionine-choline-deficient (MCD) diets for 8 weeks, wild type (WT) mice exhibited Hh pathway activation, enhanced OPN expression, and NASH-fibrosis. Ja18-/- and CD1d-/- mice which lack NKT cells had significantly attenuated Hh and OPN expression and dramatically less fibrosis. Liver mononuclear cells (LMNCs) from MCD diet fed WT mice contained activated NKT cells, generated Hh and OPN, and stimulated HSCs to become myofibroblasts; neutralising these factors abrogated the fibrogenic actions of WT LMNCs. LMNCs from NKT-cell-deficient mice were deficient in fibrogenic factors, failing to activate collagen gene expression in HSCs. Human NASH livers with advanced fibrosis contained more OPN and Hh protein than those with early fibrosis. Plasma levels of OPN mirrored hepatic OPN expression and correlated with fibrosis severity. CONCLUSION: Hepatic NKT cells drive production of OPN and Hh ligands that promote fibrogenesis during NASH. Associated increases in plasma levels of OPN may provide a biomarker of NASH fibrosis.
OBJECTIVE: Immune responses are important in dictating non-alcoholic steatohepatitis (NASH) outcome. We previously reported that upregulation of hedgehog (Hh) and osteopontin (OPN) occurs in NASH, that Hh-regulated accumulation of natural killer T (NKT) cells promotes hepatic stellate cell (HSC) activation, and that cirrhotic livers harbour large numbers of NKT cells. DESIGN: The hypothesis that activated NKT cells drive fibrogenesis during NASH was evaluated by assessing if NKT depletion protects against NASH fibrosis; identifying the NKT-associated fibrogenic factors; and correlating plasma levels of the NKT cell-associated factor OPN with fibrosis severity in mice and humans. RESULTS: When fed methionine-choline-deficient (MCD) diets for 8 weeks, wild type (WT) mice exhibited Hh pathway activation, enhanced OPN expression, and NASH-fibrosis. Ja18-/- and CD1d-/- mice which lack NKT cells had significantly attenuated Hh and OPN expression and dramatically less fibrosis. Liver mononuclear cells (LMNCs) from MCD diet fed WT mice contained activated NKT cells, generated Hh and OPN, and stimulated HSCs to become myofibroblasts; neutralising these factors abrogated the fibrogenic actions of WT LMNCs. LMNCs from NKT-cell-deficient mice were deficient in fibrogenic factors, failing to activate collagen gene expression in HSCs. Human NASH livers with advanced fibrosis contained more OPN and Hh protein than those with early fibrosis. Plasma levels of OPN mirrored hepatic OPN expression and correlated with fibrosis severity. CONCLUSION: Hepatic NKT cells drive production of OPN and Hh ligands that promote fibrogenesis during NASH. Associated increases in plasma levels of OPN may provide a biomarker of NASH fibrosis.
Authors: Wing-Kin Syn; Ye Htun Oo; Thiago A Pereira; Gamze F Karaca; Youngmi Jung; Alessia Omenetti; Rafal P Witek; Steve S Choi; Cynthia D Guy; Caitlin M Fearing; Vanessa Teaberry; Fausto E L Pereira; David H Adams; Anna Mae Diehl Journal: Hepatology Date: 2010-06 Impact factor: 17.425
Authors: Wing-Kin Syn; Youngmi Jung; Alessia Omenetti; Manal Abdelmalek; Cynthia D Guy; Liu Yang; Jiangbo Wang; Rafal P Witek; Caitlin M Fearing; Thiago A Pereira; Vanessa Teaberry; Steve S Choi; J Conde-Vancells; Gamze F Karaca; Anna Mae Diehl Journal: Gastroenterology Date: 2009-07-03 Impact factor: 22.682
Authors: Alessia Omenetti; Wing-Kin Syn; Youngmi Jung; Heather Francis; Alessandro Porrello; Rafal P Witek; Steve S Choi; Liu Yang; Marlyn J Mayo; M Eric Gershwin; Gianfranco Alpini; Anna Mae Diehl Journal: Hepatology Date: 2009-08 Impact factor: 17.425
Authors: Steve S Choi; Alessia Omenetti; Rafal P Witek; Cynthia A Moylan; Wing-Kin Syn; Youngmi Jung; Liu Yang; Debra L Sudan; Jason K Sicklick; Gregory A Michelotti; Marcos Rojkind; Anna Mae Diehl Journal: Am J Physiol Gastrointest Liver Physiol Date: 2009-10-08 Impact factor: 4.052
Authors: Wing-Kin Syn; Rafal P Witek; Stuart M Curbishley; Youngmi Jung; Steve S Choi; Barbara Enrich; Alessia Omenetti; Kolade M Agboola; Caitlin M Fearing; Herbert Tilg; David H Adams; Anna Mae Diehl Journal: Eur J Immunol Date: 2009-07 Impact factor: 5.532
Authors: Wing-Kin Syn; Steve S Choi; Evaggelia Liaskou; Gamze F Karaca; Kolade M Agboola; Ye Htun Oo; Zhiyong Mi; Thiago A Pereira; Marzena Zdanowicz; Padmini Malladi; Yuping Chen; Cynthia Moylan; Youngmi Jung; Syamal D Bhattacharya; Vanessa Teaberry; Alessia Omenetti; Manal F Abdelmalek; Cynthia D Guy; David H Adams; Paul C Kuo; Gregory A Michelotti; Peter F Whitington; Anna Mae Diehl Journal: Hepatology Date: 2010-10-21 Impact factor: 17.425
Authors: M Swiderska-Syn; W K Syn; G Xie; L Krüger; M V Machado; G Karaca; G A Michelotti; S S Choi; R T Premont; A M Diehl Journal: Gut Date: 2013-10-30 Impact factor: 23.059
Authors: Denitra A Breuer; Maria Cristina Pacheco; M Kay Washington; Stephanie A Montgomery; Alyssa H Hasty; Arion J Kennedy Journal: Am J Physiol Gastrointest Liver Physiol Date: 2019-11-11 Impact factor: 4.052
Authors: Steve S Choi; Lee C Claridge; Ravi Jhaveri; Marzena Swiderska-Syn; Paul Clark; Ayako Suzuki; Thiago A Pereira; Zhiyong Mi; Paul C Kuo; Cynthia D Guy; Fausto E L Pereira; Anna Mae Diehl; Keyur Patel; Wing-Kin Syn Journal: Clin Sci (Lond) Date: 2014-06 Impact factor: 6.124